BlackRock »

Moleculin Biotech shares owned by BlackRock

Quarter-by-quarter ownership of Moleculin Biotech (MBRX) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Moleculin Biotech

Tip: Access up to 7 years of quarterly data

All positions including Moleculin Biotech held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moleculin Biotech by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $35k 13k 2.84

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Moleculin Biotech

Armistice Capital
Vanguard Group
LPL Financial
Geode Capital Management
BlackRock
BlackRock
Renaissance Technologies
Atticus Wealth Management
Tower Research Capital
Newbridge Financial Services Group
Morgan Stanley
Bank of America Corporation
Sandy Spring Bank
CVA Family Office
Advisor Group Holdings

View all funds holding Moleculin Biotech